rs61758444
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000351513.7(DPYS):c.1423C>T(p.Arg475Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000125 in 1,613,916 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000351513.7 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DPYS | NM_001385.3 | c.1423C>T | p.Arg475Ter | stop_gained | 8/10 | ENST00000351513.7 | NP_001376.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DPYS | ENST00000351513.7 | c.1423C>T | p.Arg475Ter | stop_gained | 8/10 | 1 | NM_001385.3 | ENSP00000276651 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152076Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000135 AC: 34AN: 251044Hom.: 0 AF XY: 0.000192 AC XY: 26AN XY: 135676
GnomAD4 exome AF: 0.000127 AC: 186AN: 1461840Hom.: 0 Cov.: 32 AF XY: 0.000150 AC XY: 109AN XY: 727220
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152076Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74284
ClinVar
Submissions by phenotype
not provided Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 12, 2024 | This sequence change creates a premature translational stop signal (p.Arg475*) in the DPYS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DPYS are known to be pathogenic (PMID: 20362666). This variant is present in population databases (rs61758444, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with dihydropyrimidinuria (PMID: 20362666). ClinVar contains an entry for this variant (Variation ID: 446083). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects DPYS function (PMID: 20362666, 28642038). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jul 28, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | Oct 23, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 18, 2023 | Published functional studies found this variant is associated with significantly reduced enzyme activity and reduced protein stability (PMID: 20362666, 28642038); Nonsense variant in the C-terminus predicted to result in protein truncation, as the last 45 amino acids are lost, and other loss-of-function variants have been reported downstream in HGMD; This variant is associated with the following publications: (PMID: 25525159, 31589614, 28642038, 34426522, 20362666) - |
Dihydropyrimidinase deficiency Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 05, 2024 | Variant summary: DPYS c.1423C>T (p.Arg475X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 0.00014 in 251044 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in DPYS causing Dihydropyrimidinase Deficiency, allowing no conclusion about variant significance. c.1423C>T has been reported in the literature in at least one homozygous individual affected with Dihydropyrimidinase Deficiency (e.g. vanKuilenburg_2010). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal enzyme activity (e.g. vanKuilenburg_2010). ClinVar contains an entry for this variant (Variation ID: 446083). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | New York Genome Center | Oct 08, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Apr 04, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at